Clinical Trial Update: 'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating re-priming radiotherapy after incomplete response to CAR-T therapy in relapsed/refractory non-Hodgkin lymphoma has completed. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Non-Hodgkin Lymphoma | Phase 1, Phase 2 | Status: COMPLETED